title: Identification of key residues determining isomerohydrolase activity of human RPE65.
abstract: RPE65 is the retinoid isomerohydrolase that converts all-trans-retinyl ester to 11-cis-retinol, a key reaction in the retinoid visual cycle. We have previously reported that cone-dominant chicken RPE65 (cRPE65) shares 90% sequence identity with human RPE65 (hRPE65) but exhibits substantially higher isomerohydrolase activity than that of bovine RPE65 or hRPE65. In this study, we sought to identify key residues responsible for the higher enzymatic activity of cRPE65. Based on the amino acid sequence comparison of mammalian and other lower vertebrates' RPE65, including cone-dominant chicken, 8 residues of hRPE65 were separately replaced by their counterparts of cRPE65 using site-directed mutagenesis. The enzymatic activities of cRPE65, hRPE65, and its mutants were measured by in vitro isomerohydrolase activity assay, and the retinoid products were analyzed by HPLC. Among the mutants analyzed, two single point mutants, N170K and K297G, and a double mutant, N170K/K297G, of hRPE65 exhibited significantly higher catalytic activity than WT hRPE65. Further, when an amino-terminal fragment (Met(1)-Arg(33)) of the N170K/K297G double mutant of hRPE65 was replaced with the corresponding cRPE65 fragment, the isomerohydrolase activity was further increased to a level similar to that of cRPE65. This finding contributes to the understanding of the structural basis for isomerohydrolase activity. This highly efficient human isomerohydrolase mutant can be used to improve the efficacy of RPE65 gene therapy for retinal degeneration caused by RPE65 mutations.
authors.affiliation: Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104; Harold Hamm Diabetes Center, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104.
authors.forename: Yusuke
authors.initials: Y
authors.lastname: Takahashi
authors.affiliation: Harold Hamm Diabetes Center, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104; Department of Physiology, and University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104.
authors.forename: Gennadiy
authors.initials: G
authors.lastname: Moiseyev
authors.affiliation: Harold Hamm Diabetes Center, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104; Department of Physiology, and University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104. Electronic address: jian-xing-ma@ouhsc.edu.
authors.forename: Jian-Xing
authors.initials: JX
authors.lastname: Ma
mesh_terms: D019943:Amino Acid Substitution; D000818:Animals; D002417:Cattle; D002460:Cell Line; D002645:Chickens; D030342:Genetic Diseases, Inborn / Q000201:enzymology / Q000235:genetics / Q000628:therapy; D015316:Genetic Therapy; D006801:Humans; D016297:Mutagenesis, Site-Directed; D020125:Mutation, Missense; D012162:Retinal Degeneration / Q000201:enzymology / Q000235:genetics / Q000628:therapy; D013045:Species Specificity; D013329:Structure-Activity Relationship; D019745:cis-trans-Isomerases / Q000737:chemistry / Q000276:immunology / Q000378:metabolism; D000099178:Retinoid Isomerohydrolase
chemical_list: D019745:cis-trans-Isomerases; D000099178:Retinoid Isomerohydrolase
keywords: Enzyme Kinetics; Retina; Retinal Metabolism; Retinoid; Vitamin A
references.citation: FEBS J. 2011 Apr;278(6):973-87
references.pmid: 21235714
references.citation: Anal Biochem. 1976 May 7;72:248-54
references.pmid: 942051
references.citation: Cell. 2005 Aug 12;122(3):449-59
references.pmid: 16096063
references.citation: Eur J Hum Genet. 1998 Sep-Oct;6(5):527-31
references.pmid: 9801879
references.citation: Proc Natl Acad Sci U S A. 1998 Mar 17;95(6):3088-93
references.pmid: 9501220
references.citation: Biochemistry. 2005 May 10;44(18):7035-47
references.pmid: 15865448
references.citation: Curr Eye Res. 2008 Jan;33(1):81-90
references.pmid: 18214745
references.citation: Ophthalmic Genet. 2000 Sep;21(3):135-50
references.pmid: 11035546
references.citation: Invest Ophthalmol Vis Sci. 2001 Jun;42(7):1429-35
references.pmid: 11381042
references.citation: Invest Ophthalmol Vis Sci. 2000 Dec;41(13):4293-9
references.pmid: 11095629
references.citation: Proc Natl Acad Sci U S A. 2005 Sep 20;102(38):13658-63
references.pmid: 16150724
references.citation: Arch Ophthalmol. 2000 Apr;118(4):538-43
references.pmid: 10766140
references.citation: Gene Ther. 2005 May;12(10):843-51
references.pmid: 15789063
references.citation: FEBS J. 2009 Jun;276(11):3020-30
references.pmid: 19490105
references.citation: Electrophoresis. 1997 Dec;18(15):2714-23
references.pmid: 9504803
references.citation: Hum Gene Ther. 2008 Oct;19(10):979-90
references.pmid: 18774912
references.citation: Nat Genet. 1997 Oct;17(2):139-41
references.pmid: 9326927
references.citation: Invest Ophthalmol Vis Sci. 2006 Mar;47(3):1177-84
references.pmid: 16505056
references.citation: Proc Natl Acad Sci U S A. 2008 Sep 30;105(39):15112-7
references.pmid: 18809924
references.citation: PLoS Med. 2006 Oct;3(10):e347
references.pmid: 17032058
references.citation: Hum Mol Genet. 2001 Dec 15;10(26):3075-81
references.pmid: 11751689
references.citation: Hum Mutat. 2001 Aug;18(2):164
references.pmid: 11462243
references.citation: Mol Ther. 2008 Mar;16(3):458-65
references.pmid: 18209734
references.citation: Biochem J. 2006 Oct 1;399(1):101-9
references.pmid: 16787387
references.citation: FEBS Lett. 2005 Oct 10;579(24):5414-8
references.pmid: 16198348
references.citation: Mol Vis. 2008;14:2211-26
references.pmid: 19057658
references.citation: Mol Ther. 2003 Jun;7(6):774-81
references.pmid: 12788651
references.citation: Vision Res. 2008 Feb;48(3):377-85
references.pmid: 17950399
references.citation: N Engl J Med. 2008 May 22;358(21):2240-8
references.pmid: 18441370
references.citation: Invest Ophthalmol Vis Sci. 1994 Apr;35(5):2535-42
references.pmid: 8163342
references.citation: Invest Ophthalmol Vis Sci. 2012 May 17;53(6):3027-39
references.pmid: 22467576
references.citation: PLoS One. 2006 Dec 20;1:e38
references.pmid: 17183666
references.citation: Nat Med. 2006 Mar;12(3):348-53
references.pmid: 16491086
references.citation: Nat Genet. 2001 May;28(1):92-5
references.pmid: 11326284
references.citation: Proc Natl Acad Sci U S A. 2005 Aug 30;102(35):12413-8
references.pmid: 16116091
references.citation: N Engl J Med. 2008 May 22;358(21):2231-9
references.pmid: 18441371
references.citation: Nat Genet. 1997 Oct;17(2):194-7
references.pmid: 9326941
references.citation: J Biol Chem. 2008 Mar 28;283(13):8110-7
references.pmid: 18216020
references.citation: Proc Natl Acad Sci U S A. 1997 Sep 16;94(19):10319-23
references.pmid: 9294208
references.citation: J Neurosci. 1998 Nov 1;18(21):8936-46
references.pmid: 9786999
references.citation: Invest Ophthalmol Vis Sci. 1992 Jan;33(1):1-17
references.pmid: 1730530
references.citation: Mol Ther. 2005 Dec;12(6):1072-82
references.pmid: 16226919
references.citation: J Med Genet. 2003 Sep;40(9):709-13
references.pmid: 12960219
references.citation: Genet Vaccines Ther. 2004 Apr 27;2:3
references.pmid: 15109394
references.citation: Methods Mol Biol. 1998;89:91-104
references.pmid: 9664321
references.citation: Invest Ophthalmol Vis Sci. 2000 Aug;41(9):2735-42
references.pmid: 10937591
references.citation: Invest Ophthalmol Vis Sci. 2007 Jul;48(7):3324-8
references.pmid: 17591905
references.citation: Invest Ophthalmol Vis Sci. 2003 Apr;44(4):1663-72
references.pmid: 12657607